Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.
de Mulder M, Yebra G, Navas A, de José MI, Gurbindo MD, González-Tomé MI, Mellado MJ, Saavedra-Lozano J, Muñoz-Fernández MÁ, de Ory SJ, Ramos JT, Holguín A; Madrid Cohort of HIV-Infected Children. de Mulder M, et al. PLoS One. 2012;7(12):e52155. doi: 10.1371/journal.pone.0052155. Epub 2012 Dec 17. PLoS One. 2012. PMID: 23284913 Free PMC article.
Microsporidiosis in HIV-positive children in Madrid (Spain).
Del Aguila C, Navajas R, Gurbindo D, Ramos JT, Mellado MJ, Fenoy S, Muñoz Fernandez MA, Subirats M, Ruiz J, Pieniazek NJ. Del Aguila C, et al. J Eukaryot Microbiol. 1997 Nov-Dec;44(6):84S-85S. doi: 10.1111/j.1550-7408.1997.tb05798.x. J Eukaryot Microbiol. 1997. PMID: 9580074
Lopinavir/r versus nelfinavir as salvage therapy.
Resino S, Alvaro-Meca A, de José MI, Gurbindo MD, Ramos JT, Martin-Fontelos P, Muñoz-Fernández MA. Resino S, et al. Pediatr Infect Dis J. 2005 Apr;24(4):392-3. doi: 10.1097/01.inf.0000157922.19139.90. Pediatr Infect Dis J. 2005. PMID: 15818313 Clinical Trial. No abstract available.
[Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers].
Ramos JT, de José MI, Polo R, Fortuny C, Mellado MJ, Muñoz-Fernández MA, Beceiro J, Bertrán JM, Calvo C, Chamorro L, Ciria L, Guillén S, González-Montero R, González-Tomé MI, Gurbindo MD, Martín-Fontelos P, Martínez-Pérez J, Moreno D, Muñoz-Almagro MC, Mur A, Navarro ML, Otero C, Rojo P, Rubio B, Saavedra J; Grupo Colaborativo Español de VIH Pediátrico (CEVIHP); Sociedad Española de Infectologia Pediátrica (SEIP); Asociacion Española de Pediatría (AEP); Plan Nacional sobre el SIDA del Ministerio de Sanidad y Consumo. Ramos JT, et al. Enferm Infecc Microbiol Clin. 2005 May;23(5):279-312. doi: 10.1157/13074970. Enferm Infecc Microbiol Clin. 2005. PMID: 15899180 Review. Spanish.
Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals.
Ramos JT, De José MI, Dueñas J, Fortuny C, González-Montero R, Mellado MJ, Mur A, Navarro M, Otero C, Pocheville I, Muñoz-Fernández MA, Cabrero E; Spanish Collaborative Group on HIV Infection in Children. Ramos JT, et al. Pediatr Infect Dis J. 2005 Oct;24(10):867-73. doi: 10.1097/01.inf.0000180574.18804.90. Pediatr Infect Dis J. 2005. PMID: 16220083 Clinical Trial.
497 results